NVOON
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Name NVOON
Rank No.1619
Market Cap $2.15M
Fully Diluted Market Cap $2.15M
Market Share %
Trading Vol/Market Cap (24H) 2,596.19%
Circulation Supply 52.80K
Max Supply 0
Total Supply 52,796.90436633
Circulation Rate %
Issue Date --
The price at which the asset was first issued --
All-Time High 64.27358143874574, 2026-01-23
Lowest Price 35.19686383702467, 2026-03-30
Public Blockchain NVOON
Introduction Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Sector
- common.mc-trade-zone-xStocks
Social Media
Fund Flow Analysis
|
Buy(NVOON) |
Sell(NVOON) |
Net Inflow |
| Big |
0.000 |
0.000 |
0.000 |
| Medium |
0.000 |
0.000 |
0.000 |
| Small |
99.270 |
141.710 |
-42.440 |
| Total |
99.270 |
141.710 |
-42.440 |
Disclaimer: Data provided by cmc and should not be considered as investment advice.